BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 13, 2013
View Archived Issues
Preventive effects of diabetes medications in combating stroke
Read More
First-in-human study of Dompe's rhNGF eye drops in healthy subjects
Read More
Novel biomarkers for early detection of renal cell carcinoma identified
Read More
SynBio begins dosing in phase III ErepoXen study
Read More
Vitamin D deficiency and its impact on inflammatory markers in patients with diabetic foot
Read More
Phase II results reported for ETC-1002 in patients with diabetes and dyslipidemia
Read More
Nippon Shinyaku plans to conduct clinical study of Duchenne muscular dystrophy treatment
Read More
New androgen receptor modulators patented by Eli Lilly
Read More
Roche and Genentech present new BACE1 inhibitors
Read More
Canadian researchers divulge novel protein kinase inhibitors for cancer
Read More
Orgenesis and ATMI enter into process development agreement for diabetes
Read More
Trevena and Forest Laboratories collaborate on TRV-027
Read More
Unigene and Nordic Bioscience enter license agreement for metabolic peptide analogues
Read More
Creabilis' topical Trk-A inhibitor CT-327 shows promise
Read More
Genmab's antibody-drug conjugate evaluated in vitro and in vivo
Read More
Oregon Therapeutics identifies compounds active against drug-resistant cancer cells
Read More
Novartis obtains FDA approval for Ilaris in active systemic juvenile idiopathic arthritis
Read More
Confirmatory phase III study of BromSite begins
Read More
Biotie reports initiation of NIH-funded study of nepicastat in cocaine dependence
Read More
Novel chimeric antigen receptors presented by HHS
Read More
Dose-escalation begins in phase I/II study of MyeloXen vaccine for multiple sclerosis
Read More
Adaptive Biotechnologies enters into biomarker collaboration with Bristol-Myers Squibb
Read More
Mitsubishi Tanabe Pharma: fiscal 2012 in review
Read More
Recothrom approved for use in children age 1 month or older
Read More
Amgen and Zhejiang Beta Pharma form joint venture in China
Read More
FDA approves Breo Ellipta for treatment of COPD
Read More